Centre in talks with Assam Petrochemicals, others to secure methanol supply for pharma amid West Asia disruptions

Supply chain resilience is critical for the pharmaceutical sector, especially for key raw materials. Geopolitical tensions can significantly impact global trade.

Bullish for the Indian pharma sector due to proactive government measures. Specifically positive for companies like GNFC involved in methanol production.

For Indian markets, this story mainly matters for GNFC and the pharma pocket. The current signal is bullish, so traders should look for follow-through in price, volume, and sector breadth instead of reacting to the headline alone.

Watch whether the next market session confirms the setup described here: Direct engagement with the government to secure methanol supply for a critical sector. Also track volume confirmation, sector participation, and whether the move holds beyond the first reaction.

• •India is working to secure methanol for its pharmaceutical sector.
• •Global supply chains face disruptions due to the West Asia crisis.
• •Discussions are underway with Assam Petrochemicals and GNFC.
• •Efforts focus on ensuring adequate methanol availability and logistics.
• •Risk flag: Prolonged geopolitical instability.